Private Equity

Dealmaking

Deals

Why a Korean shareholder dispute could spark more buyouts

A recent fracas marks the latest in a string of negative headlines for Korean private equity, which some industry participants fear could impact dealmaking activity in the near-term.

3 min read · 15 March 2021

Deals

Behind the scenes of CVC's investment in Carlyle-backed MedRisk

Increased infrastructure spending will only fuel demand for the workers comp services provided by MedRIsk, whose new backer CVC is fielding inbounds around its future M&A strategy.

4 min read · 12 March 2021

Deals

Wind Point to drive channel partnerships at FoodScience

The PE firm’s latest acquisition of the heritage vitamin brand builds on its health and wellness strategy.

2 min read · 12 March 2021

Deals

Stone Point readies sale of Grace Hill, a real estate software provider  

The firm has hired William Blair to provide financial advice on the sale process, which is expected to kick off soon, sources said.

1 min read · 12 March 2021

Deals

A hybrid offering model may slow the SPAC craze

VC managers are waking up to SPACs as an alternative to an offering model that has long been outdated. But a combination of traditional IPO, direct listing and staggered lock-up release could be a future offering model.

3 min read · 12 March 2021

Hot public markets lend to scarcity problem for PE, Lindsay Goldberg hires first-ever woman partner

Reflecting on the SPACs frenzy

3 min read · 12 March 2021

GPs, LPs flock to sector specialization in wake of lock down, GTCR teams up with execs to form healthcare platform

Debating specialist funds versus generalists

2 min read · 11 March 2021

Deals

GTCR forms Epselon to build another healthcare platform

In partnership with Michael Mulhern and Phil Macnabb - executives with whom GTCR has partnered five and four times, respectively - Epselon will leverage the seasoned leaders' experiences building companies "around the plumbing of the healthcare industry," the firm's Cunningham said.

3 min read · 10 March 2021

Acacia-backed Red River runs sale process, L Catterton, Littlejohn-backed PatientPoint Health Technologies surpasses $1b valuation

Acacia-backed Red River hits the market and L Catterton-backed PatientPoint merges with Littlejohn & Co’s Outcome Health.

2 min read · 10 March 2021

Deals

PatientPoint-Outcome Health marriage pushes valuation north of $1bn

PatientPoint will remain majority owned by a group of investors including L Catterton and LittleJohn, although the exact ownership structure is unclear.

3 min read · 10 March 2021

Showing 7,381 to 7,390 of 42,641 results
1…738740…1000